ARSENAULT KAITLYN (Chief Financial Officer) received a stock award from SKYE BIOSCIENCE, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/29/2023ACC: 0001516551-23-000064
Officer· Chief Financial Officer
Since Oct 2021
+16.73M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
16.73M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+13.38M
Price / share
—
Trade value
—
% of position
1338.2%
8/25/2023
1M→14.38M
Total
Net shares
+13.38M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2023 | A · Award | +13.38M | — | — | 1338.2% | 1M | 14.38M |
| Total | +13.38M | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
3.35M shares
Shares
+3.35M
Strike price
0.014
Held after
3.35M
Exercisable
—
8/25/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock3.35M shares | 8/25/2023 | A · Award | +3.35M | 0.014 | — | 3.35M |